Articles with public access mandates - Roberta RoncaratiLearn more
Available somewhere: 12
Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy
R Roncarati, C Viviani Anselmi, MA Losi, L Papa, E Cavarretta, ...
Journal of the American College of Cardiology 63 (9), 920-927, 2014
Mandates: Fondazione Cariplo, European Commission
Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy
R Roncarati, C Viviani Anselmi, P Krawitz, G Lattanzi, Y Von Kodolitsch, ...
European Journal of Human Genetics 21 (10), 1105-1111, 2013
Mandates: Government of Italy
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable …
C Viviani Anselmi, C Briguori, R Roncarati, L Papa, G Visconti, A Focaccio, ...
JACC: Cardiovascular Interventions 6 (11), 1166-1175, 2013
Mandates: Government of Italy
Assessment of the 9p21. 3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes
NV Rivera, R Carreras-Torres, R Roncarati, C Viviani-Anselmi, ...
BMC Medical Genetics 14, 1-8, 2013
Mandates: Government of Italy
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis
E Dika, E Broseghini, E Porcellini, M Lambertini, M Riefolo, G Durante, ...
Cell Death & Disease 12 (5), 473, 2021
Mandates: AIRC Foundation for Cancer Research in Italy
Unexpectedly low mutation rates in beta‐myosin heavy chain and cardiac myosin binding protein genes in italian patients with hypertrophic cardiomyopathy
R Roncarati, MVG Latronico, B Musumeci, S Aurino, A Torella, ML Bang, ...
Journal of cellular physiology 226 (11), 2894-2900, 2011
Mandates: Fondazione Telethon, Italy
ARID1A in cancer: Friend or foe?
B Fontana, G Gallerani, I Salamon, I Pace, R Roncarati, M Ferracin
Frontiers in oncology 13, 1136248, 2023
Mandates: AIRC Foundation for Cancer Research in Italy
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer
R Roncarati, L Lupini, E Miotto, E Saccenti, S Mascetti, L Morandi, C Bassi, ...
Molecular oncology 14 (9), 2163-2175, 2020
Mandates: Government of Italy
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease
I Salamon, E Biagini, P Kunderfranco, R Roncarati, M Ferracin, N Taglieri, ...
Cell Death & Disease 12 (12), 1150, 2021
Mandates: Government of Italy
MicroRNA signatures predict early major coronary events in middle-aged men and women
B Gigante, L Papa, A Bye, P Kunderfranco, C Viviani, R Roncarati, ...
Cell Death & Disease 11 (1), 74, 2020
Mandates: Swedish Research Council, Government of Italy
Monitoring somatic genetic alterations in circulating cell-free DNA/RNA of patients with “oncogene-addicted” advanced lung adenocarcinoma: a real-world clinical study
L Lupini, R Roncarati, L Belluomini, F Lancia, C Bassi, L D’Abundo, ...
International Journal of Molecular Sciences 23 (15), 8546, 2022
Mandates: Government of Italy
Reply: platelet reactivity is preferred over genotyping in monitoring efficacy of antiplatelet therapy
C Viviani Anselmi, C Briguori, R Roncarati, L Papa, G Visconti, A Focaccio, ...
JACC: Cardiovascular Interventions 7 (4), 448-449, 2014
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program